Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in MyoCardial Infarction (AMICI)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2013 by Angioblast Systems
Sponsor:
Collaborators:
Mesoblast, Inc.
Mesoblast, Ltd.
Teva Pharmaceuticals USA
Information provided by (Responsible Party):
Angioblast Systems
ClinicalTrials.gov Identifier:
NCT01781390
First received: January 14, 2013
Last updated: April 29, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)